Can Patients With COPD Assimilate Disease-Specific Information During an Acute Exacerbation?: Results of a Pilot Randomized Controlled Trial

Tania Janaudis-Ferreira; Sylvia Jocelyn Carr; Samantha L Harrison; Andrea S Gershon; Siobhan C Milner; Sean Carr; David Fishbein; Roger Goldstein

doi:10.1016/j.chest.2018.05.028

Can Patients With COPD Assimilate Disease-Specific Information During an Acute Exacerbation?: Results of a Pilot Randomized Controlled Trial

Chest. 2018 Sep;154(3):588-596. doi: 10.1016/j.chest.2018.05.028. Epub 2018 Jun 4.

Authors

Tania Janaudis-Ferreira¹, Sylvia Jocelyn Carr², Samantha L Harrison³, Andrea S Gershon⁴, Siobhan C Milner⁵, Sean Carr⁶, David Fishbein⁶, Roger Goldstein⁷

Affiliations

¹ School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada; Translational Research in Respiratory Diseases Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada; Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada. Electronic address: Tania.janaudis-ferreira@mcgill.ca.
² Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada.
³ Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada; School of Health and Social Care, Teesside University, Middlesbrough, England.
⁴ Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
⁵ School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada.
⁶ Department of Medicine, Humber River Hospital, Toronto, ON, Canada.
⁷ Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.

PMID: 29879395
DOI: 10.1016/j.chest.2018.05.028

Abstract

Background: The study aimed to determine the feasibility and effectiveness of an introductory disease-specific educational program delivered during an acute exacerbation of COPD (AECOPD) on objective measures of disease-specific knowledge.

Methods: Patients admitted to a community hospital with an AECOPD were randomly assigned to a control group (standard care) or intervention group (standard care + brief education). The intervention group received two 30-min education sessions in hospital or at home within 2 weeks of hospital admission. Feasibility measures included the number of eligible patients, compliance with the sessions, and number of follow-up measures completed. Disease-specific knowledge and informational needs were measured using the Bristol COPD Knowledge Questionnaire (BCKQ) and the Lung Information Needs Questionnaire (LINQ), respectively, before and after the intervention period.

Results: Thirty-one patients (mean age, 72 ± 10 years) with an AECOPD participated in the study. Of 102 approached patients, 75 consented to screening (73.5%) and 67 (66%) were eligible for the study. Thirty-four patients declined participation. All intervention patients (n = 15) completed the educational sessions and follow-up measures. Three patients (control group) did not complete the follow-up measures. The mean changes and SDs for the BCKQ in the intervention and control groups were 8 ± 5.14 and 3.4 ± 4.9, respectively (P = .02). No difference between groups was found for the LINQ (P = .80).

Conclusions: A brief educational program delivered at the time of hospitalization for an AECOPD was feasible for a subset of patients, resulted in improved disease-specific knowledge, and may be a bridge to more active approaches.

Trial registry: ClinicalTrials.gov; No.: NCT02321215; URL: www.clinicaltrials.gov.

Keywords: COPD; education; exacerbation; hospitalization; self-management.

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Female
Health Knowledge, Attitudes, Practice
Hospitalization
Humans
Male
Patient Education as Topic*
Pilot Projects
Pulmonary Disease, Chronic Obstructive / physiopathology*
Pulmonary Disease, Chronic Obstructive / therapy*
Surveys and Questionnaires

Associated data

ClinicalTrials.gov/NCT02321215